Lafayette, LANCT07525375Now EnrollingIRB Ready

Asthma Clinical Trial in Lafayette, LA

Access cutting-edge asthma treatment through this clinical trial at a research site in Lafayette. Study-provided care at no cost to qualified participants.

Sponsored by AstraZeneca

Quick Self-Assessment

See if you qualify for this Lafayette location

Preparing your pre-screening questions…

Expert Care in Lafayette

Access asthma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related asthma treatment provided free

Apply for This Lafayette Location

Check if you qualify for this asthma clinical trial in Lafayette, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lafayette

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lafayette site if eligible
  4. 4Begin participation

About This Asthma Study in Lafayette

The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

Sponsor: AstraZeneca

Who Can Participate

Inclusion Criteria

Participants who have a documented history of physician-diagnosed asthma
Participants who have been using a stable and regular inhaled corticosteroid plus one additional asthma controller medication.
Participants must have a Childhood Asthma Control Test score ≥ 19.
Participants must have a pre-bronchodilator FEV1 ≤ 95% of predicted normal value.
Body mass index (BMI) ≤ 95 percentile for age and body weight of ≥ 14 kg or higher.
Female participants who experience menarche must have a negative urine pregnancy test.
Received no asthma medication other than run-in BFF MDI BID and albuterol/salbutamol as needed. Main

Exclusion Criteria

Life-threatening asthma defined as a history of significant asthma episode(s) requiring intubation associated with hypercapnia, respiratory arrest, hypoxic seizures, or asthma-related syncopal episode(s).
Historical or current evidence of a clinically significant disease including, but not limited to cardiovascular, hepatic, renal, hematological, neurological, endocrine, gastrointestinal, or pulmonary.
Any clinically relevant abnormal findings in physical examination, clinical chemistry, hematology, vital signs, or ECG.
Hospitalization for asthma
Narrow-angle glaucoma not adequately treated and/or change in vision, bladder dysfunction, bladder outlet obstruction/urinary retention or any other conditions where anticholinergic treatment is contraindicated and may be relevant.
Use of Long-acting muscarinic antagonist (LAMA), either alone or as part of an inhaled combination therapy.
Current use of any systemic beta-blockers.
Respiratory infection involving antibiotic treatment.
Systemic corticosteroid use for any reason (including asthma exacerbations).
Participants with a known hypersensitivity to beta 2-agonists, corticosteroids, anticholinergics, or any component of the MDI.
Participants who are medically unable to withhold their short-acting bronchodilators and other asthma medications.
Any use of marketed (eg, omalizumab, mepolizumab, benralizumab, reslizumab) or investigational biologic.
Regular use of a nebulizer or a home nebulizer for receiving asthma medications.
Use of any immunomodulators or immunosuppressive medication.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lafayette?

Yes, this clinical trial (NCT07525375) has an active research site in Lafayette, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Asthma Treatment Options in Lafayette, LA

If you're searching for asthma treatment options in Lafayette, LA, this clinical trial (NCT07525375) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lafayette research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all asthma clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Lafayette, LA

See all ankylosing spondylitis clinical trials recruiting in Lafayette — not just this study.

Browse Ankylosing Spondylitis Trials in Lafayette →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsAsthma TrialsPediatric Asthma TrialsModerate-to-Severe Asthma TrialsAll Conditions →

Ready to Join in Lafayette?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lafayette, LA